First-lineLustral
Sertraline
SSRI
First-line antidepressant in pregnancy and breastfeeding.
Oral
First-line for
- Depression in pregnancy
- Postnatal depression
- Anxiety disorders, OCD, PTSD in perinatal period
Mechanism
Selective serotonin reuptake inhibition at SERT → ↑ synaptic 5-HT.
"Sertraline stays low in milk"
- Relative infant dose <2% — first-choice SSRI in lactation
- Onset 4–6 weeks — warn about initial anxiety spike
- Wean to avoid discontinuation syndrome
Dosing
- Start
- 50 mg OD (25 mg if anxious presentation)
- Titrate
- Increase by 50 mg every 2–4 weeks; max 200 mg/day
Contraindications
- AbsoluteConcurrent MAOI (serotonin syndrome)
- CautionBleeding disorders, epilepsy
Side effects
- Nausea, diarrhoea (first weeks)
- Sexual dysfunction
- Insomnia or somnolence
- Hyponatraemia (SIADH, elderly)
Fetal & maternal notes
- • No teratogenic signal
- • Late 3rd trimester: neonatal adaptation syndrome (jittery, feeding difficulty) — do NOT stop, self-limits in <2 weeks
- • PPHN absolute risk <1%
Key interactions
Tramadol / pethidine / linezolid
AvoidSerotonin syndrome
NSAIDs / aspirin
Caution↑ GI bleed risk
Warfarin
Caution↑ INR, bleeding
Clinical pearls
- 💡 Do not stop untreated depression in pregnancy — untreated illness carries greater fetal risk
- 💡 Talking therapy always offered alongside medication
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.